Michele De Tursi Selected Research

Michele De Tursi Research Topics

Disease

31	Neoplasms (Cancer) 01/2022 - 11/2010
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 10/2015
9	Breast Neoplasms (Breast Cancer) 01/2021 - 05/2009
5	Neoplasm Metastasis (Metastasis) 12/2021 - 11/2010
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2016
5	Lung Neoplasms (Lung Cancer) 01/2020 - 06/2007
4	Prostatic Neoplasms (Prostate Cancer) 04/2022 - 10/2017
4	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 09/2014
3	Disease Progression 01/2021 - 11/2020
3	Overweight 10/2020 - 01/2019
2	Human Influenza (Influenza) 01/2020 - 10/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 09/2018 - 05/2012
2	Venous Thromboembolism 12/2016 - 11/2010
2	Thrombosis (Thrombus) 10/2015 - 04/2011
1	Exanthema (Rash) 03/2022
1	Pancytopenia 01/2022
1	Neutropenia 12/2021
1	Obesity 10/2020
1	Sarcopenia 01/2020
1	Chronic Disease (Chronic Diseases) 01/2020
1	Cysts 01/2020
1	Neuroendocrine Carcinoma 01/2020
1	Inflammation (Inflammations) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Fatigue 11/2019
1	Weight Loss (Weight Reduction) 09/2019
1	Stomach Neoplasms (Stomach Cancer) 09/2019
1	Body Weight (Weight, Body) 09/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Triple Negative Breast Neoplasms 03/2018
1	Pain (Aches) 10/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2017
1	Multiple Myeloma 12/2016
1	Hemorrhage 12/2016

Drug/Important Bio-Agent (IBA)

11	Immune Checkpoint InhibitorsIBA 02/2021 - 10/2018
5	ErbB Receptors (EGF Receptor)IBA 03/2022 - 10/2015
5	Tyrosine Kinase InhibitorsIBA 01/2022 - 11/2013
5	pembrolizumabIBA 01/2021 - 10/2020
4	Pharmaceutical PreparationsIBA 01/2021 - 06/2016
3	Panitumumab (Vectibix)FDA Link 03/2022 - 09/2014
3	Cetuximab (Erbitux)FDA Link 03/2022 - 01/2017
3	Biological ProductsIBA 01/2022 - 01/2019
3	Sunitinib (Sutent)FDA Link 01/2021 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2018
3	Hormones (Hormone)IBA 01/2019 - 02/2013
3	Trastuzumab (Herceptin)FDA Link 11/2013 - 05/2009
2	Bevacizumab (Avastin)FDA Link 12/2021 - 01/2019
2	Monoclonal AntibodiesIBA 12/2021 - 01/2019
2	AndrogensIBA 10/2020 - 10/2017
2	cabozantinibIBA 10/2020 - 01/2020
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2020 - 10/2018
2	Axitinib (AG 013736)IBA 01/2019 - 01/2016
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2018 - 01/2017
2	Abiraterone AcetateIBA 11/2017 - 10/2017
2	Gefitinib (Iressa)FDA Link 01/2017 - 06/2007
1	osimertinibIBA 01/2022
1	Growth Factor ReceptorsIBA 12/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Proton Pump InhibitorsIBA 01/2021
1	Long-Acting Thyroid Stimulator (LATS)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2020
1	AnticoagulantsIBA 11/2020
1	Opioid Analgesics (Opioids)IBA 11/2020
1	B7-H1 AntigenIBA 11/2020
1	SteroidsIBA 11/2020
1	alectinibIBA 01/2020
1	ORALIT (ORS)IBA 01/2020
1	pertuzumabIBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 01/2020
1	CrizotinibIBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	LigandsIBA 01/2020
1	RamucirumabIBA 09/2019
1	exemestane (Aromasin)FDA Link 01/2019
1	palbociclibIBA 01/2019
1	Everolimus FDA Link 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Nelfinavir (Viracept)FDA Link 09/2018
1	nitroxolineIBA 09/2018
1	Pemetrexed (MTA)FDA Link 01/2018
1	PlatinumIBA 01/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 10/2017
1	AfatinibIBA 01/2017
1	AntithrombinsIBA 12/2016
1	semuloparinIBA 12/2016
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2016
1	Heparin (Liquaemin)FDA LinkGeneric 12/2016
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2016
1	Factor Xa InhibitorsIBA 12/2016
1	Vitamin K FDA Link 12/2016
1	Warfarin (Coumadin)FDA LinkGeneric 12/2016

Therapy/Procedure

18	Drug Therapy (Chemotherapy) 01/2021 - 11/2010
17	Therapeutics 01/2022 - 05/2014
12	Immunotherapy 04/2022 - 01/2018
3	Castration 04/2022 - 10/2017
3	Neoadjuvant Therapy 04/2019 - 02/2013
1	Time-to-Treatment 01/2018